Received May 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | A5DP7 | IM / LA |
Patient received first dose of Hep B vaccine on April 27th, 2026. She felt itchy at injection site, the next day she noticed a raised rash that was tender to touch, itchy and hard. Applied cold compresses. After 7 days, rash still present measuring 50mm x 50mm, continuing with symptoms of tenderness, itchiness and hardened.
unknown
unknown
unknown
environmental: pollen
assessment on May 5th, 2026